Helen Katherine Ellias's Insider Trades & SAST Disclosures
Helen Katherine Ellias's most recent trade in SAB Biotherapeutics Inc was a trade of 35,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on Nov. 1, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Helen Katherine Ellias.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| SAB Biotherapeutics Inc | Helen Katherine Ellias | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Nov 2024 | 35,000 | 35,000 | - | - | Stock Option (right to buy) | |
| SAB Biotherapeutics Inc | Helen Katherine Ellias | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Nov 2024 | 20,000 | 20,000 | - | - | Stock Option (right to buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges